CARDINAL HEALTH INC (CAH)
US14149Y1082 - Common Stock
ChartMill assigns a Buy % Consensus number of 72% to CAH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 129.69. This target is 9.65% above the current price.
CAH was analyzed by 22 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about CAH.
In the previous month the buy percentage consensus was at a similar level.
CAH was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-12-13 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2024-11-04 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-11-04 | UBS | Maintains | Buy -> Buy |
| 2024-11-04 | Deutsche Bank | Maintains | Hold -> Hold |
| 2024-11-04 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-04 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-10-22 | UBS | Maintains | Buy -> Buy |
| 2024-09-11 | Argus Research | Maintains | Buy -> Buy |
| 2024-08-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-16 | Deutsche Bank | Maintains | Hold -> Hold |
| 2024-08-15 | UBS | Maintains | Buy -> Buy |
| 2024-08-15 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2024-08-15 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-08-15 | Baird | Maintains | Outperform -> Outperform |
| 2024-08-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-07-19 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-07-09 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-07-09 | Baird | Maintains | Outperform -> Outperform |
| 2024-05-15 | Argus Research | Maintains | Buy -> Buy |
| 2024-05-03 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-05-03 | Baird | Maintains | Outperform -> Outperform |
| 2024-04-29 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2024-02-26 | Leerink Partners | Initiate | Outperform |
| 2024-02-09 | Argus Research | Upgrade | Hold -> Buy |
| 2024-02-05 | UBS | Maintains | Buy -> Buy |
| 2024-01-29 | UBS | Maintains | Buy -> Buy |
| 2024-01-03 | Barclays | Initiate | Overweight |
| 2023-12-14 | Wells Fargo | Initiate | Underweight |
| 2023-11-17 | JP Morgan | Maintains | Neutral -> Neutral |